Showing results (91-100 of 154) with videos related to

Sort By:
Pageof 16
Anticancer Research|December 8, 2019
Volume-Time Index Is Not an Indicator of Outcome for Patients Undergoing CRS/HIPEC for Treatment of High-Grade Appendiceal CarcinomatosisDaniel M Dotta, Joshua D Lansom, Oliver M Fisher, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 19, 2018
Biosimilarity and Interchangeability: Principles and Evidence: A Systematic ReviewRoss A McKinnon, Matthew Cook, Winston Liauw, et al.
Australian Journal of Primary Health|April 20, 2026
Feasibility study of a colorectal cancer e-care plan for shared follow-up survivorship careJane Taggart, Melvin Chin, Winston Liauw, et al.
BMC Health Services Research|November 21, 2021
"Time is of the essence": relationship between hospital staff perceptions of time, safety attitudes and staff wellbeingLouise A Ellis, Yvonne Tran, Chiara Pomare, et al.
Journal of Gastrointestinal Oncology|April 30, 2019
The effect of intraoperative fluid administration on outcomes of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapyRaphael Shamavonian, Rohan McLachlan, Oliver M Fisher, et al.
Cancer|June 22, 2010
Intra-arterial iodine-131-lipiodol for unresectable hepatocellular carcinomaTerence C Chua, Francis Chu, S Patrick Butler, et al.
BMJ Open Gastroenterology|March 3, 2023
Age-related experiences of colorectal cancer diagnosis: a secondary analysis of the English National Cancer Patient Experience SurveySyeda Somyyah Owais, Gaston Arnolda, Klay Lamprell, et al.
Palliative & Supportive Care|July 9, 2026
Potentially burdensome end-of-life care for colorectal cancer decedents: A retrospective cohort studyGifty Varghese, Tolesa Okuba, Geoffrey Delaney, et al.
Asia-Pacific Journal of Clinical Oncology|February 22, 2011
The pharmacological advantage of prolonged dose rate gemcitabine is restricted to patients with variant alleles of cytidine deaminase c.79A>CEkkaphon Metharom, Peter Galettis, Susan Manners, et al.
World Journal of Surgical Oncology|July 23, 2025
Overall survival post secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent colorectal cancer with peritoneal metastasesRaymond Hayler, Celine Garrett, Jessica Guo, et al.
Pageof 16